C07D 211/56
Nitrogen atoms
Official title: Nitrogen atoms (nitro radicals C07D211/38)
C07D211/56 (Nitrogen atoms) appears on 1,849 US grants and 1,721 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,849
- Published applications
- 1,721
- Assignees
- 804
- Inventors
- 5,476
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 16 | 0 |
| 1977 | 27 | 0 |
| 1978 | 22 | 0 |
| 1979 | 20 | 0 |
| 1980 | 24 | 0 |
| 1981 | 14 | 0 |
| 1982 | 16 | 0 |
| 1983 | 9 | 0 |
| 1984 | 15 | 0 |
| 1985 | 18 | 0 |
| 1986 | 16 | 0 |
| 1987 | 9 | 0 |
| 1988 | 18 | 0 |
| 1989 | 19 | 0 |
| 1990 | 26 | 0 |
| 1991 | 25 | 0 |
| 1992 | 22 | 0 |
| 1993 | 27 | 0 |
| 1994 | 28 | 0 |
| 1995 | 29 | 0 |
| 1996 | 35 | 0 |
| 1997 | 41 | 0 |
| 1998 | 40 | 0 |
| 1999 | 41 | 0 |
| 2000 | 43 | 0 |
| 2001 | 37 | 5 |
| 2002 | 56 | 51 |
| 2003 | 56 | 91 |
| 2004 | 40 | 117 |
| 2005 | 40 | 102 |
| 2006 | 58 | 104 |
| 2007 | 44 | 77 |
| 2008 | 49 | 81 |
| 2009 | 73 | 92 |
| 2010 | 62 | 93 |
| 2011 | 51 | 71 |
| 2012 | 70 | 53 |
| 2013 | 59 | 54 |
| 2014 | 57 | 71 |
| 2015 | 50 | 67 |
| 2016 | 49 | 69 |
| 2017 | 72 | 63 |
| 2018 | 43 | 60 |
| 2019 | 50 | 53 |
| 2020 | 36 | 59 |
| 2021 | 47 | 48 |
| 2022 | 39 | 56 |
| 2023 | 27 | 56 |
| 2024 | 28 | 48 |
| 2025 | 32 | 47 |
| 2026 | 24 | 33 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Inhibitors of spinster homolog 2 (SPNS2) for use in therapy22 Sep 2026US 12,741,944 B2University of Virginia Patent Foundation
- Lactone and lactam containing compounds useful as immunomodulators1 Sep 2026US 12,723,041 B2Bristol-Myers Squibb Company
- Process for preparing N,N′-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine25 Aug 2026US 12,715,845 B2BASF SE
- Small molecule inhibitors of mammalian SLC6A19 function11 Aug 2026US 12,703,692 B2Jnana Therapeutics Inc.
- Usp30 inhibitors and uses thereof1 Oct 2026US 2026/0297026 A1Vincere Biosciences, Inc.
- Substituted triazine compound1 Oct 2026US 2026/0297040 A1
- Cyclohexyl or heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorders characterised by hyperglycaemia17 Sep 2026US 2026/0274785 A1Atrogi AB
- Novel compound, and pharmaceutical composition comprising same as active ingredient10 Sep 2026US 2026/0265189 A1Sapiensbio Inc.
- Aromatic compounds for use as protein phosphatase 2a (pp2a) modulators10 Sep 2026US 2026/0265190 A1Rappta Therapeutics Oy
Most cited
By later US patents
- Inhibitors of microsomal triglyceride transfer protein and method137US 5,712,279 ABristol-Myers Squibb Company · 1998
- Urea derivatives and their use as ACAT inhibitors134US 5,621,010 ANisshin Flour Milling Co., Ltd. · 1997
- Inhibitors of microsomal triglyceride transfer protein and method129US 5,739,135 ABristol-Myers Squibb Company · 1998
- Nucleic acids encoding microsomal trigyceride transfer protein128US 5,595,872 ABristol-Myers Squibb Company · 1997
- 4-substituted piperidine derivatives123US 7,572,913 B2Bioaxone Therapeutique Inc. · 2009